Following an expert meeting at Venice, Italy, this year, the ATP project participants from South Africa (Rabogajane Busang and Rosemary Wolson) compiled a brief guide to socially responsible licensing for technology transfer offices based on input from experts at the Venice meeting. This guide seeks to provide technology transfer offices with some guidelines on how to implement Socially Responsible Licensing practices when carrying out their IP management & commercialisation activities. This is an easy to understand guide with examples of clauses provided in the appendices. The aim is to translate the theoretical concept of Socially Responsible Licensing into a more practical, easy to implement concept. We hope that this guide will lead to increased implementation of Socially Responsible Licensing practices in an effort to alleviate the problem of access to healthcare technologies in poorer countries.
The guide can be downloaded from this link
The ATP consortium, through the efforts of the South African Medical Research Council (SAMRC), hosted an expert workshop on Socially Responsible Licensing (SRL) in Venice, Italy. The workshop involved experts in the field of technology transfer and intellectual property law. The aim of the workshop was to share recent case studies on Socially Responsible Licensing, including Patent Analytics, and the drafting of an SRL guide for technology transfer offices. The workshop participants made highly informative presentations and shared ideas on the drafting of the SRL guide. The drafting of the guide is currently underway and the manual will be distributed to the TTO’s once completed. The participants of the workshop were as follows:
(from left to right) Back row: Anna Meijknecht, Stan Kowalski, Rabojagane Busang, Anatole Krattiger, Ashley Stevens. Front row: Carol Mimura, Rosemary Wolson, Harry Thangaraj, Naseema Sonday, Lita Nelsen
• Ashley Stevens (President, Focus IP Group LLC, USA)
Case Study: A Treatment for Vitiligo Developed by a Start-Up
• Lita Nelsen (Director: Technology Licensing Office, Massachusetts Institute of Technology, USA)
Access to Vital Medicines: A case study 25 years of Licensing at MIT: what have we learned?
• Carol Mimura (Assistant Vice Chancellor for IPIRA, University of California Berkeley, USA)
Global Public-Private Partnerships Collaboration to Traverse Funding Gaps & Maximize Social Impact
• Anatole Krattiger (Director, Global Challenges Division, WIPO, Switzerland)
Case study on “Socially Responsible Licensing”
• Anna Meijknecht (Assistant Professor: Public International Law, Human Rights Law and Minority Rights Law, Law Faculty, Tilburg University, Netherlands)
• Rabogajane Busang (Division Manager, Technology Transfer, SAMRC, South Africa)
• Rosemary Wolson (Senior IP Manager: CSIR, South Africa)
Transforming Ideas into Innovations, Licensing and Ventures
• Harry Thangaraj (Director ATP Project: St George’s University London, UK)
The Access to Pharmaceuticals Project
• Stanley Kowalski (Law Professor, University of New Hampshire Law School, USA)
Patent Landscape Analyses of Health Innovations
Application to Intellectual Property and Technology-transfer Strategies to Accelerate Global Access
• Naseema Sonday (Research Assistant, ATP Project, SAMRC, South Africa)
A paper arising from the ATP project that reviews case studies relating to product development and delivery by selected product development partnerships (PDP) is available as an open access publication:
Title: Product Development Partnerships: Case studies of a new mechanism for health technology innovation.
Journal: Health Research Policy and Systems 2011, 9:33
Author: Richard Mahoney. International Vaccine Institute (IVI)
There is a continuing need for new health technologies to address the disease burdens of developing countries. In the last decade Product Development Partnerships (PDP) have emerged that are making important contributions to the development of these technologies. PDPs are a form of public private partnerships that focus on health technology development. PDPs reflect the current phase in the history of health technology development: the Era of Partnerships, in which the public and private sectors have found productive ways to collaborate. Successful innovation depends on addressing six determinants of innovation. We examine four case studies of PDPs and show how they have addressed the six determinants to achieve success.
Download the paper here ….
The objectives of Socially Responsible Licensing (SRL) are mainly to ensure that licensing of intellectual assets is negotiated and transacted in a manner conducive to providing access to essential medicines and other life enhancing innovations. The goals of SRL are to make available to society globally, but in particular to developing countries, such technologies at affordable prices and to make proprietary research tools widely available for the advancement of knowledge. This can be achieved by adopting licensing practices which add a dimension of social responsibility to the pursuit of economic objectives, without necessarily compromising the latter. This approach does not affect business transactions in developed countries where significant profits can still be achieved but ensures access for the least developed countries, which are often disregarded in commercialization strategies due to perceived low profitability. This paper addresses recent developments in South Africa, specifically the newly enacted legislation on IP emanating from publicly funded research, and some practical examples of how SRL strategies can be implemented.
Socially Responsible Licensing Of Health Technologies- Policy And Practice In South Africa
Rabogajane Busang, Karine Boisjoly-Letourneau, Bernard Fourie, Michelle Mulder and Harry Thangaraj
Journal of the Licensing Executives Society International (les Nouvelles). June, 2011 – Volume XLVI No. 2
Neuchâtel, 18 October 2010. How can biomedical and pharmaceutical research and development be stimulated in Switzerland in order to fight neglected diseases (Chagas, Dengue fever or river blindness)? A researcher of the Institute of Health Law at the University of Neuchâtel sheds light on this question in a book that has just been released. Read more on the UNINE page…
As part of our research on compulsory licensing we have now added a case study on efavirenz – the antiretroviral that Brazil needed for its public funded HIV treatment program. Brazil was forced to do so because of failure of negotiation for a voluntary license by the patent holder, Merck. This case is the first addition to a new section entitled: Case Studies in Global Health
Global Health Forum (GHF) was set up by graduate students on the MBBS 4 course in 2007. On coming to St Georges these students felt there could be more opportunities to learn about global health issues, and share news and ideas within the medical school. Through sending monthly emails about various Global health events in London and getting speakers in to St Georges twice termly GHF aims to be a platform from which these ideas can be discussed and spread. Read more about our activities and creation of a local UAEM (universities allied for essential medicines) chapter at St George’s…
This is our space for news, opinion and announcements
Rich Mahoney from the IVI has kindly made available the presentations and meetings from the 2009 PDP workshop in New York in the staff pages.